Incremental prognostic value of pretreatment exosomal miR-6763-5p for postoperative progression-free survival in epithelial ovarian cancer
Frontiers in Oncology · 18.11.2026 · 16
DOI: 10.3389/fonc.2026.2022299 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Oncology, online erschienen am 18.11.2026. Verfasst von Yuanyuan Guo und 7 weiteren Autor:innen. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Epithelial ovarian cancer (EOC) has a high recurrence rate and lacks reliable noninvasive prognostic biomarkers. Our previous work showed that plasma exosomal miR-4479 and miR-6763-5p have diagnostic value, but their prognostic role is unclear. This study aimed to evaluate their associations with postoperative progression-free survival (PFS) and assess the incremental prognostic value of miR-6763-5p in EOC.
Methods
This single-center prospective study included 126 newly diagnosed EOC patients. Associations with PFS were analyzed using Kaplan–Meier and Cox regression. Incremental value was assessed by nested model comparisons, with internal validation using 1,000 bootstrap resamples.
Results
During follow-up, 72 PFS events occurred. Low miR-6763-5p expression was significantly associated with poorer PFS (HR = 0.500, P = 0.004). Adding miR-6763-5p to the clinical model significantly improved model fit (likelihood ratio test: χ² = 8.319, P = 0.004), indicating additional prognostic information beyond conventional clinicopathological factors.
Discussion
Pretreatment plasma exosomal miR-6763-5p provides incremental prognostic information for postoperative PFS in EOC, but external validation is required before clinical use.
Zitieren
APA
Guo, Y., Wang, S., Xu, N., Cui, R., Sun, H., Pang, S., Chen, L., & Zhang, F. (2026). Incremental prognostic value of pretreatment exosomal miR-6763-5p for postoperative progression-free survival in epithelial ovarian cancer. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.2022299
Vancouver
Guo Y, Wang S, Xu N, Cui R, Sun H, Pang S, et al. Incremental prognostic value of pretreatment exosomal miR-6763-5p for postoperative progression-free survival in epithelial ovarian cancer. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.2022299
BibTeX
@article{Guo2026,
author = {Guo, Yuanyuan and Wang, Shiwen and Xu, Nuo and Cui, Ruyue and Sun, Haorui and Pang, Shuya and Chen, Liang and Zhang, Fang},
title = {Incremental prognostic value of pretreatment exosomal miR-6763-5p for postoperative progression-free survival in epithelial ovarian cancer},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.2022299}
}
EUVIMED